| 000 | 01636 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514000321.0 | ||
| 264 | 0 | _c20010521 | |
| 008 | 200105s 0 0 eng d | ||
| 022 | _a0735-1097 | ||
| 024 | 7 |
_a10.1016/s0735-1097(01)01194-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aParaskevaidis, I A | |
| 245 | 0 | 0 |
_aDobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption: 18-month follow-up study. _h[electronic resource] |
| 260 |
_bJournal of the American College of Cardiology _cMay 2001 |
||
| 300 |
_a1685-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCardiomyopathy, Dilated _xclassification |
| 650 | 0 | 4 | _aCardiotonic Agents |
| 650 | 0 | 4 | _aDobutamine |
| 650 | 0 | 4 |
_aEchocardiography _xmethods |
| 650 | 0 | 4 |
_aExercise Test _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOxygen Consumption |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aStroke Volume |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aVentricular Function, Left |
| 700 | 1 | _aAdamopoulos, S | |
| 700 | 1 | _aKremastinos, D T | |
| 773 | 0 |
_tJournal of the American College of Cardiology _gvol. 37 _gno. 6 _gp. 1685-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0735-1097(01)01194-9 _zAvailable from publisher's website |
| 999 |
_c11278093 _d11278093 |
||